Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK. SÆBY ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   2.5% 10.2% 9.2% 8.8% 7.6% 7.4% 23.6% 21.1%   Credit score (0-100)   64 25 26 27 31 32 4 5   Credit rating   BBB BB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,363 1,417 1,087 887 978 1,204 0.0 0.0   EBITDA   502 -81.6 -370 -126 -22.2 230 0.0 0.0   EBIT   470 -114 -405 -133 -33.1 216 0.0 0.0   Pre-tax profit (PTP)   468.8 -114.2 -412.8 -138.6 -56.3 201.1 0.0 0.0   Net earnings   342.5 -114.2 -412.8 -138.5 -56.3 201.1 0.0 0.0   Pre-tax profit without non-rec. items   469 -114 -413 -139 -56.3 201 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   69.3 37.3 31.5 23.6 44.7 30.5 0.0 0.0   Shareholders equity total   826 658 245 106 49.9 251 0.9 0.9   Interest-bearing liabilities   0.0 0.0 19.1 73.2 175 0.0 0.0 0.0   Balance sheet total (assets)   1,090 757 434 320 316 386 0.9 0.9   Net Debt   -960 -628 -49.2 34.9 153 -54.9 -0.9 -0.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,363 1,417 1,087 887 978 1,204 0.0 0.0   Gross profit growth   5.5% 4.0% -23.3% -18.4% 10.2% 23.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,090 757 434 320 316 386 1 1   Balance sheet change%   53.6% -30.6% -42.6% -26.4% -1.2% 22.1% -99.8% 0.0%   Added value   502.2 -81.6 -370.2 -125.6 -25.3 229.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -64 -64 -41 -16 10 -29 -30 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 -3.0 -4.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   34.5% -8.0% -37.3% -15.0% -3.4% 17.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   52.2% -12.3% -67.8% -33.9% -8.8% 63.2% 0.0% 0.0%   ROI %   69.0% -15.3% -87.6% -57.7% -13.9% 93.1% 0.0% 0.0%   ROE %   50.3% -15.4% -91.5% -79.0% -72.2% 133.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   75.7% 86.9% 56.3% 33.2% 15.8% 65.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -191.1% 769.8% 13.3% -27.8% -689.8% -23.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 7.8% 68.9% 350.5% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 95.9% 23.1% 22.8% 23.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.8 7.1 2.0 1.3 1.0 2.5 0.0 0.0   Current Ratio   3.8 7.1 2.0 1.3 1.0 2.5 0.0 0.0   Cash and cash equivalent   960.0 627.9 68.3 38.4 21.9 54.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   739.9 603.7 196.8 66.1 -11.4 204.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   502 -82 -370 -126 -25 230 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   502 -82 -370 -126 -22 230 0 0   EBIT / employee   470 -114 -405 -133 -33 216 0 0   Net earnings / employee   343 -114 -413 -139 -56 201 0 0